Carlini M, Lonardo M T, Carboni F, Petric M, Lepiane P, Santoro E
Division of Digestive Surgery and Liver Transplantation, Regina Elena Institute for Cancer Research, Rome, Italy.
J Exp Clin Cancer Res. 2002 Mar;21(1):15-21.
Aim of this study is to define feasibility and effectiveness of the transhiatal esophagogastric resection in cardia adenocarcinoma. From 1981 to 2001, we submitted to surgery 85 patients affected by cardia adenocarcinoma. Since 1994, 34 patients, in consideration of clinical, anatomosurgical (Siewert II-III) and pathologic (T1-3, cN mediastinal negative) findings, underwent transhiatal esophagogastric resection according to Pinotti's technique. This consisted in the midline opening of the central tendon of the diaphragm, ligature and section of the left inferior phrenic vessels, exposure and anterior retraction of the pericardium. The approach allowed in all cases a satisfactory esophageal mobilization and a good dissection of the inferior mediastinal structures avoiding thoracotomy. Postoperative complications were observed in 8 patients (24%). In 4 cases the complications were medical (11.8%) and in 4 cases surgical (11.8%). Death occurred in 4 cases (11.8%): in 3 patients (8.8%) for local complications (2 anastomotic leaks and 1 hemorrage) and in 1 (2.9%) for cardiac failure. The 26 non complicated cases had an uneventful postoperative course and were discharged 12 days after surgery. Middle and long term results were evaluated in terms of locoregional recurrence rate and actuarial survival. At 1 and 2 years locoregional recurrence occurred in 8.8% and 11.8% of cases respectively. Five-year overall survival was 22.5%. In selected cases (Siewert type II-III, T1-3 tumors with clinically negative mediastinal lymphnodes) the procedure in study appears technically feasible, it provides a satisfactory volume of esophageal exeresis and an adequate extension of mediastinal lymphadenectomy, representing a safe and effective alternative to thoracotomy in cardia cancer surgery.
本研究的目的是确定经裂孔食管胃切除术治疗贲门腺癌的可行性和有效性。1981年至2001年,我们对85例贲门腺癌患者进行了手术治疗。自1994年以来,考虑到临床、解剖手术(Siewert II - III型)和病理(T1 - 3,纵隔cN阴性)结果,34例患者根据皮诺蒂技术接受了经裂孔食管胃切除术。该手术包括在膈肌中心腱作中线切口,结扎并切断左膈下血管,暴露心包并向前牵拉。该入路在所有病例中均能实现满意的食管游离和良好的纵隔下部结构解剖,避免了开胸手术。8例患者(24%)出现术后并发症。其中4例为内科并发症(11.8%),4例为外科并发症(11.8%)。4例患者(11.8%)死亡:3例患者(8.8%)死于局部并发症(2例吻合口漏和1例出血),1例患者(2.9%)死于心力衰竭。26例无并发症的患者术后恢复顺利,术后12天出院。从中期和长期结果评估局部区域复发率和精算生存率。1年和2年时局部区域复发率分别为8.8%和11.8%。五年总生存率为22.5%。在选定的病例(Siewert II - III型,纵隔淋巴结临床阴性的T1 - 3肿瘤)中,本研究中的手术在技术上似乎可行,它能提供满意的食管切除范围和充分的纵隔淋巴结清扫范围,是贲门癌手术中开胸手术的一种安全有效的替代方法。